Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Higher concentrations of bitter melon extract increase hair growth, with 15% being the most effective.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

60% of women who didn't respond to 5% minoxidil for hair loss showed significant improvement with a 15% minoxidil solution.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Skin problems like acne and excessive hair growth are common in people with Polycystic Ovarian Syndrome, especially those with 15-16 follicles in their ovaries.

Using more than 5% minoxidil can help hair growth more, but results vary and side effects may increase.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Human hair follicle stem cells can be isolated using specific markers for potential therapeutic use.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Markers help differentiate between apocrine and eccrine sweat glands to identify sweat gland tumors.

Disrupting Smad4 in mouse skin causes early hair follicle stem cell activity that leads to their eventual depletion.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Hair follicle stem cells can turn into various cell types and help repair nerves.

Scientists created a long-lasting stem cell line from human hair that can turn into different skin and hair cell types.

Damage to hair follicle stem cells causes permanent hair loss and scarring in cutaneous lupus erythematosus.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Eruptive vellus hair cysts can run in families.

Inflammation and immunity play a key role in androgenetic alopecia, with better treatment outcomes in certain immune-positive cases.

Mast cells might contribute to hair loss by causing skin thickening.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Researchers found two genes that may explain why some Casertana pigs don't have hair.